Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (cellbank.brc@riken.jp).
10106
Nohmi T, Masumura K, Toyoda-Hokaiwado N.
Transgenic rat models for mutagenesis and carcinogenesis.Genes Environ
2017
39:11
PubMed ID: 28174618
DOI: 10.1186/s41021-016-0072-6
2125
Hamaguchi T, Matsuoka Y, Bechberger J, Ohnishi T, Fujita K, Naus CC, Kusunoki M, Tsubura A, Tsuda H.
Establishment of an apoptosis-sensitive rat mammary carcinoma cell line with a mutation in the DNA-binding region of p53Cancer Lett
2006
232(2):279-88
PubMed ID: 15876486
DOI: 10.1016/j.canlet.2005.02.043